293 related articles for article (PubMed ID: 27863261)
21. Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma.
Sudha P; Ahsan A; Ashby C; Kausar T; Khera A; Kazeroun MH; Hsu CC; Wang L; Fitzsimons E; Salminen O; Blaney P; Czader M; Williams J; Abu Zaid MI; Ansari-Pour N; Yong KL; van Rhee F; Pierceall WE; Morgan GJ; Flynt E; Gooding S; Abonour R; Ramasamy K; Thakurta A; Walker BA
Clin Cancer Res; 2022 Jul; 28(13):2854-2864. PubMed ID: 35522533
[TBL] [Abstract][Full Text] [Related]
22. Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma.
Smadbeck J; Peterson JF; Pearce KE; Pitel BA; Figueroa AL; Timm M; Jevremovic D; Shi M; Stewart AK; Braggio E; Riggs DL; Bergsagel PL; Vasmatzis G; Kearney HM; Hoppman NL; Ketterling RP; Kumar S; Rajkumar SV; Greipp PT; Baughn LB
Blood Cancer J; 2019 Dec; 9(12):103. PubMed ID: 31844041
[TBL] [Abstract][Full Text] [Related]
23. Advances in the pathogenesis and diagnosis of multiple myeloma.
Chesi M; Bergsagel PL
Int J Lab Hematol; 2015 May; 37 Suppl 1():108-14. PubMed ID: 25976968
[TBL] [Abstract][Full Text] [Related]
24. Genomics of Multiple Myeloma.
Robiou du Pont S; Cleynen A; Fontan C; Attal M; Munshi N; Corre J; Avet-Loiseau H
J Clin Oncol; 2017 Mar; 35(9):963-967. PubMed ID: 28297630
[TBL] [Abstract][Full Text] [Related]
25. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.
Chesi M; Kuehl WM; Bergsagel PL
Ann Oncol; 2000; 11 Suppl 1():131-5. PubMed ID: 10707795
[TBL] [Abstract][Full Text] [Related]
26. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.
Kim ST; Lee WS; Lanman RB; Mortimer S; Zill OA; Kim KM; Jang KT; Kim SH; Park SH; Park JO; Park YS; Lim HY; Eltoukhy H; Kang WK; Lee WY; Kim HC; Park K; Lee J; Talasaz A
Oncotarget; 2015 Nov; 6(37):40360-9. PubMed ID: 26452027
[TBL] [Abstract][Full Text] [Related]
27. NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial.
Rosa-Rosa JM; Cuenca I; Medina A; Vázquez I; Sánchez-delaCruz A; Buenache N; Sánchez R; Jiménez C; Rosiñol L; Gutiérrez NC; Ruiz-Heredia Y; Barrio S; Oriol A; Martin-Ramos ML; Blanchard MJ; Ayala R; Ríos-Tamayo R; Sureda A; Hernández MT; de la Rubia J; Alkorta-Aranburu G; Agirre X; Bladé J; Mateos MV; Lahuerta JJ; San-Miguel JF; Calasanz MJ; Garcia-Sanz R; Martínez-Lopez J
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291952
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel fusion transcripts in multiple myeloma.
Lin M; Lee PL; Chiu L; Chua C; Ban KHK; Lin AHF; Chan ZL; Chung TH; Yan B; Chng WJ
J Clin Pathol; 2018 Aug; 71(8):708-712. PubMed ID: 29453220
[TBL] [Abstract][Full Text] [Related]
29. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
[TBL] [Abstract][Full Text] [Related]
30. The clinical characteristics and prognosis of IGH deletion in multiple myeloma.
He H; Fu W; Jiang H; Du J; Zhou L; Zhang C; Xi H; Li R; Hou J
Leuk Res; 2015 May; 39(5):515-9. PubMed ID: 25817540
[TBL] [Abstract][Full Text] [Related]
31. Whole Exome Sequencing in Multiple Myeloma to Identify Somatic Single Nucleotide Variants and Key Translocations Involving Immunoglobulin Loci and MYC.
Walker BA
Methods Mol Biol; 2018; 1792():71-95. PubMed ID: 29797253
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples.
Dallol A; Buhmeida A; Al-Ahwal MS; Al-Maghrabi J; Bajouh O; Al-Khayyat S; Alam R; Abusanad A; Turki R; Elaimi A; Alhadrami HA; Abuzenadah M; Banni H; Al-Qahtani MH; Abuzenadah AM
J Transl Med; 2016 May; 14(1):118. PubMed ID: 27146902
[TBL] [Abstract][Full Text] [Related]
33. Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma.
Rustad EH; Hultcrantz M; Yellapantula VD; Akhlaghi T; Ho C; Arcila ME; Roshal M; Patel A; Chen D; Devlin SM; Jacobsen A; Huang Y; Miller JE; Papaemmanuil E; Landgren O
PLoS One; 2019; 14(3):e0211600. PubMed ID: 30901326
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic deep-targeted next-generation sequencing assessment of TP53 gene mutations in multiple myeloma from the whole bone marrow.
Petrackova A; Minarik J; Sedlarikova L; Libigerova T; Hamplova A; Krhovska P; Balcarkova J; Pika T; Papajik T; Kriegova E
Br J Haematol; 2020 May; 189(4):e122-e125. PubMed ID: 32130732
[No Abstract] [Full Text] [Related]
35. Next-generation sequencing is highly sensitive for the detection of beta-catenin mutations in desmoid-type fibromatoses.
Aitken SJ; Presneau N; Kalimuthu S; Dileo P; Berisha F; Tirabosco R; Amary MF; Flanagan AM
Virchows Arch; 2015 Aug; 467(2):203-10. PubMed ID: 25838078
[TBL] [Abstract][Full Text] [Related]
36. The molecular spectrum and clinical impact of DIS3 mutations in multiple myeloma.
Weißbach S; Langer C; Puppe B; Nedeva T; Bach E; Kull M; Bargou R; Einsele H; Rosenwald A; Knop S; Leich E
Br J Haematol; 2015 Apr; 169(1):57-70. PubMed ID: 25521164
[TBL] [Abstract][Full Text] [Related]
37. Microhomology-mediated end joining drives complex rearrangements and overexpression of
Mikulasova A; Ashby C; Tytarenko RG; Qu P; Rosenthal A; Dent JA; Ryan KR; Bauer MA; Wardell CP; Hoering A; Mavrommatis K; Trotter M; Deshpande S; Yaccoby S; Tian E; Keats J; Auclair D; Jackson GH; Davies FE; Thakurta A; Morgan GJ; Walker BA
Haematologica; 2020 Apr; 105(4):1055-1066. PubMed ID: 31221783
[No Abstract] [Full Text] [Related]
38. [Cytogenetic abnormalities in high-risk multiple myeloma].
Ishida T
Nihon Rinsho; 2015 Jan; 73(1):28-32. PubMed ID: 25626299
[TBL] [Abstract][Full Text] [Related]
39. 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.
Avet-Loiseau H; Garand R; Lodé L; Robillard N; Bataille R
Semin Oncol; 2003 Apr; 30(2):153-5. PubMed ID: 12720126
[TBL] [Abstract][Full Text] [Related]
40. Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletions.
Chang H; Sloan S; Li D; Keith Stewart A
Br J Haematol; 2004 Nov; 127(3):280-4. PubMed ID: 15491286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
